The OI Suite platform empowers researchers and diagnostics developers to explore diverse hypotheses and rapidly build robust models - without the need for AI expertise or extensive data.
OI Suite offers fast, user-friendly, and data-efficient AI, enabling the creation of models for a wide range of applications. It supports in-depth research and accelerates drug development and clinical trials, even with minimal labeled data.
CanvOI is a state-of-the-art vision foundation model designed to decode cancer from biopsy images, developed in collaboration with Oracle and The Ellison Institute of Technology.
Surpassing leading AI models in digital pathology, CanvOI has achieved industry-leading performance in tasks related to breast, colorectal, and lung cancers, demonstrating even higher performance than other models when using limited data.
Powered by CanvOI, our OI Suite enables cancer researchers to generate novel insights and develop cutting-edge applications by creating AI models, explaining key tissue features driving predictions, and unlocking deep data insights - all without requiring AI expertise or vast datasets.
Read CanvOI Scientific paper
